Acquisition by Chen Wei Wei of 36300 shares of LianBio ADR subject to Rule 16b-3
LIANDelisted Stock | USD 2.18 0.05 2.24% |
About 61% of LianBio ADR's investor base is looking to short. The analysis of current outlook of investing in LianBio ADR suggests that many traders are alarmed regarding LianBio ADR's prospects. LianBio ADR's investing sentiment overview a quick insight into current market opportunities from investing in LianBio ADR. Many technical investors use LianBio ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
LianBio |
Filed transaction by Lianbio director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
LianBio ADR Fundamental Analysis
We analyze LianBio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LianBio ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LianBio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
LianBio ADR is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
LianBio ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LianBio ADR stock to make a market-neutral strategy. Peer analysis of LianBio ADR could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics with similar companies.
Peers
LianBio ADR Related Equities
TIL | Instil Bio | 2.52 | ||||
SNSE | Sensei Biotherapeutics | 2.33 | ||||
TERN | Terns Pharmaceuticals | 2.12 | ||||
INZY | Inozyme Pharma | 1.68 | ||||
LRMR | Larimar Therapeutics | 0.98 | ||||
ASMB | Assembly Biosciences | 0.20 | ||||
ELDN | Eledon Pharmaceuticals | 0.45 | ||||
DAWN | Day One | 0.47 | ||||
HOOK | Hookipa Pharma | 0.47 | ||||
NUVB | Nuvation Bio | 0.76 | ||||
NXTC | NextCure | 0.92 | ||||
FENC | Fennec Pharmaceuticals | 0.98 | ||||
ABOS | Acumen Pharmaceuticals | 1.93 | ||||
ACHL | Achilles Therapeutics | 2.94 | ||||
VRCA | Verrica Pharmaceuticals | 5.00 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
CEOs Directory Screen CEOs from public companies around the world | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Stocks Directory Find actively traded stocks across global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |